These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20121572)

  • 21. Duration of viral shedding and factors associated with prolonged shedding among inpatients with influenza treated with oseltamivir: a prospective cohort study.
    Khoury J; Szwarcwort M; Kra-Oz Z; Saffuri M; Seh K; Yahalomi T; Braun E; Azzam ZS; Paul M; Neuberger A
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):319-323. PubMed ID: 29143145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The respiratory microbiota: associations with influenza symptomatology and viral shedding.
    Lee KH; Foxman B; Kuan G; López R; Shedden K; Ng S; Balmaseda A; Gordon A
    Ann Epidemiol; 2019 Sep; 37():51-56.e6. PubMed ID: 31451313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A school outbreak of pandemic (H1N1) 2009 infection: assessment of secondary household transmission and the protective role of oseltamivir.
    Leung YH; Li MP; Chuang SK
    Epidemiol Infect; 2011 Jan; 139(1):41-4. PubMed ID: 20561390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case characteristics and use of oseltamivir in children and household contacts.
    Fallo AA; Contrini MM; Neyro S; López EL
    Pediatr Infect Dis J; 2012 Jul; 31(7):781-3. PubMed ID: 22466323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.
    Lina B; Boucher C; Osterhaus A; Monto AS; Schutten M; Whitley RJ; Nguyen-Van-Tam JS
    Influenza Other Respir Viruses; 2018 Mar; 12(2):267-278. PubMed ID: 29265727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment.
    Hayden FG; Asher J; Cowling BJ; Hurt AC; Ikematsu H; Kuhlbusch K; Lemenuel-Diot A; Du Z; Meyers LA; Piedra PA; Takazono T; Yen HL; Monto AS
    Clin Infect Dis; 2022 Feb; 74(3):532-540. PubMed ID: 34245250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.
    Rath BA; Brzostek J; Guillén S; Niranjan V; Chappey C; Rayner CR; Clinch B
    Antivir Ther; 2015; 20(8):815-25. PubMed ID: 26015411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
    Carrat F; Duval X; Tubach F; Mosnier A; Van der Werf S; Tibi A; Blanchon T; Leport C; Flahault A; Mentré F;
    Antivir Ther; 2012; 17(6):1085-90. PubMed ID: 22910171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
    Le QM; Wertheim HF; Tran ND; van Doorn HR; Nguyen TH; Horby P;
    N Engl J Med; 2010 Jan; 362(1):86-7. PubMed ID: 20007549
    [No Abstract]   [Full Text] [Related]  

  • 32. Roche perspectives on Tamiflu.
    Clinch B; Smith J
    Clin Microbiol Infect; 2015 Mar; 21(3):226-9. PubMed ID: 25716982
    [No Abstract]   [Full Text] [Related]  

  • 33. The virologist and the flu.
    Wicker S; Rabenau HF
    J Clin Virol; 2015 Aug; 69():200-2. PubMed ID: 26209407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of human influenza A(H7N9) infection in Hong Kong.
    Leung YH; To MK; Lam TS; Yau SW; Leung OS; Chuang SK
    J Microbiol Immunol Infect; 2017 Apr; 50(2):183-188. PubMed ID: 26220305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):149-50. PubMed ID: 17465078
    [No Abstract]   [Full Text] [Related]  

  • 38. Oseltamivir- and amantadine-resistant influenza virus A (H1N1).
    Cheng PK; To AP; Leung TW; Leung PC; Lee CW; Lim WW
    Emerg Infect Dis; 2010 Jan; 16(1):155-6. PubMed ID: 20031069
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and molecular evidence for transmission of novel influenza A(H1N1/2009) on a commercial airplane.
    Ooi PL; Lai FY; Low CL; Lin R; Wong C; Hibberd M; Tambyah PA
    Arch Intern Med; 2010 May; 170(10):913-5. PubMed ID: 20498421
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of Household Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
    Komeda T; Takazono T; Hosogaya N; Ogura E; Fujiwara M; Miyauchi H; Ajisawa Y; Iwata S; Watanabe H; Honda K; Kitanishi Y; Hara K; Mukae H
    Clin Infect Dis; 2021 Jun; 72(11):e859-e867. PubMed ID: 33103200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.